Korean Drug Co. Ltd (014570) — Free Cash Flow Generation Index
Korean Drug Co. Ltd (014570) has a Free Cash Flow Generation Index of 0.98x as of March 2026. Free cash flow of ₩6.47 Billion represents 1% of operating cash flow (₩6.60 Billion). Read debt load of Korean Drug Co. Ltd for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Korean Drug Co. Ltd Free Cash Flow Generation Index (2014–2025)
Historical FCF Generation Index trend for Korean Drug Co. Ltd across 11 annual periods. Explore Korean Drug Co. Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Korean Drug Co. Ltd (2014–2025)
Year-by-year Free Cash Flow Generation Index for Korean Drug Co. Ltd. For the full company profile including market capitalisation, see 014570 company net worth.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.96x | ₩12.63 Billion | ₩13.11 Billion | ₩475.05 Million | ▲ +22.6% |
| 2024 | 0.79x | ₩3.83 Billion | ₩4.87 Billion | ₩1.04 Billion | ▲ +923.3% |
| 2022 | -0.10x | ₩-564.37 Million | ₩5.91 Billion | ₩6.09 Billion | ▼ -111.0% |
| 2021 | 0.87x | ₩7.65 Billion | ₩8.81 Billion | ₩1.15 Billion | ▼ -7.5% |
| 2020 | 0.94x | ₩11.57 Billion | ₩12.33 Billion | ₩738.47 Million | ▼ -37.1% |
| 2019 | 1.49x | ₩9.26 Billion | ₩6.21 Billion | ₩3.05 Billion | ▲ +21.8% |
| 2018 | 1.22x | ₩7.09 Billion | ₩5.79 Billion | ₩1.30 Billion | ▼ -65.3% |
| 2017 | 3.53x | ₩1.58 Billion | ₩447.20 Million | ₩1.13 Billion | ▲ +216.4% |
| 2016 | 1.12x | ₩4.42 Billion | ₩3.96 Billion | ₩460.84 Million | ▼ -2.4% |
| 2015 | 1.14x | ₩7.01 Billion | ₩6.13 Billion | ₩878.05 Million | ▲ +2.0% |
| 2014 | 1.12x | ₩5.00 Billion | ₩4.46 Billion | ₩538.19 Million | — |